Drug class
Peptide hormone; antidiabetic agent
Mechanism of action
Activates the insulin receptor tyrosine kinase, promoting peripheral glucose uptake (especially in skeletal muscle and adipose tissue) and inhibiting hepatic glucose production. It also inhibits lipolysis and proteolysis and promotes glycogen, lipid and protein synthesis.
General use cases
- Treatment of diabetes mellitus, including type 1 diabetes and type 2 diabetes when insulin therapy is required.
- Management of hyperglycaemia in selected acute-care settings with appropriate intravenous insulin formulations.
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
